Brittany Duvall
Family · Duarte, CANPI 1922581941
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Jazz Pharmaceuticals Inc. accounts for 91.4% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $11,675, more than ten times the $369 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $182.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$14K
- AbbVie$178
- Sanofi$151
- Bristol Myers Squibb$119
- Merck$116
- Takeda Pharmaceuticals U.S.A., Inc.$108
- plus $628 from 14 others
What the payments were for
- Consulting fees$2,00013%
- Speaking & faculty fees$8,38555%
- Travel & lodging$2,51217%
- Food & beverage$2,26315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 28 | $13,861 |
| AbbVie | 7 | $178 |
| Sanofi | 7 | $151 |
| Bristol Myers Squibb | 5 | $119 |
| Merck | 5 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Iovance Biotherapeutics, Inc. | 1 | $74 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Incyte Corporation | 3 | $64 |
| Novartis | 2 | $57 |
| EMD Serono, Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $47 |
| Seagen Inc. | 2 | $44 |
| Amgen | 3 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Karyopharm Therapeutics Inc. | 1 | $32 |
| AstraZeneca | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEFITELIO$13,466
How this compares
$15,161 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Posaconazole | 12 | $18,909 |
| Atovaquone | 14 | $5,358 |
| Ursodiol | 19 | $1,022 |
| Pantoprazole Sodium | 17 | $320 |
| Ondansetron OdtOndansetron | 14 | $274 |
| Acyclovir | 25 | $188 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 13 | $101 |
Paid to pharmacies, not to this prescriber.
Other family in Duarte
- Maria Elena Dela RosaDuarte$55K
- Marjorie HeinDuarte$50K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.